Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants - Nature.com

VisMederi S.r.l, Siena, Italy

VisMederi Research S.r.l., Siena, Italy

Department of Medical Sciences, Infectious and Tropical Diseases Unit, Siena University Hospital, Siena, Italy

Department of Medical Biotechnologies, University of Siena, Siena, Italy

Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy

Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy

You can also search for this author in

You can also search for this author in

You can also search for this author in

You can also search for this author in

You can also search for this author in

You can also search for this author in

You can also search for this author in

You can also search for this author in

You can also search for this author in

You can also search for this author in

You can also search for this author in

You can also search for this author in

You can also search for this author in

You can also search for this author in

You can also search for this author in

You can also search for this author in